News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ParagonRx Names William L. Holden To Lead Pharmaceutical Safety Strategies


7/7/2010 11:03:42 AM

WILMINGTON, Del.--(BUSINESS WIRE)--ParagonRx, an inVentiv Health, Inc. company (Nasdaq: VTIV) and a leading consulting company specializing in pharmaceutical risk management and optimizing medication, has named William L. (Billy) Holden as chief safety officer. Holden has almost 20 years experience working at top levels for major drug companies in the areas of pharmacoepidemiology, signal detection and risk management.

Read at BioSpace.com


comments powered by Disqus
ParagonRx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES